Vitali Sintchenko Selected Research

Acellular Vaccines

11/2015	Pertactin negative Bordetella pertussis demonstrates higher fitness under vaccine selection pressure in a mixed infection model.
10/2014	Investigating genome reduction of Bordetella pertussis using a multiplex PCR-based reverse line blot assay (mPCR/RLB).
4/2012	Newly emerging clones of Bordetella pertussis carrying prn2 and ptxP3 alleles implicated in Australian pertussis epidemic in 2008-2010.
6/2009	Rapid and accurate typing of Bordetella pertussis targeting genes encoding acellular vaccine antigens using real time PCR and High Resolution Melt analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vitali Sintchenko Research Topics

Disease

16	Whooping Cough (Pertussis) 12/2022 - 06/2009
13	Infections 01/2022 - 07/2005
8	Tuberculosis (Tuberculoses) 12/2021 - 04/2010
3	Coinfection 01/2022 - 11/2015
3	COVID-19 01/2022 - 09/2020
3	Human Influenza (Influenza) 12/2020 - 09/2009
2	Reinfection 12/2021 - 01/2018
2	Communicable Diseases (Infectious Diseases) 01/2021 - 01/2004
2	Pneumococcal Infections 10/2020 - 11/2018
2	Pneumonia (Pneumonitis) 10/2020 - 07/2007
2	Pulmonary Tuberculosis 03/2020 - 10/2019
1	Salmonella Infections (Salmonellosis) 12/2020
1	Botulism 09/2015
1	Bacillary Dysentery (Shigellosis) 08/2015
1	Extensively Drug-Resistant Tuberculosis 04/2015
1	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 09/2014
1	Sepsis (Septicemia) 01/2011
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2011
1	Ventilator-Associated Pneumonia 01/2006

Drug/Important Bio-Agent (IBA)

13	VaccinesIBA 12/2022 - 01/2011
6	Pharmaceutical PreparationsIBA 12/2021 - 09/2014
4	AntigensIBA 01/2021 - 01/2011
4	pertactin FDA Link 01/2020 - 04/2014
4	Acellular VaccinesIBA 11/2015 - 06/2009
3	Anti-Bacterial Agents (Antibiotics)IBA 12/2020 - 07/2005
3	Virulence Factors (Pathogenicity Factors)IBA 01/2020 - 01/2017
2	AntibodiesIBA 01/2021 - 09/2020
2	Nucleic AcidsIBA 09/2020 - 10/2019
2	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 10/2018
2	Isoniazid (Ftivazide)FDA LinkGeneric 01/2011 - 04/2010
1	Subgenomic RNAIBA 01/2022
1	N-(2-cyanoethylene)urea (BA 1)IBA 01/2022
1	NucleotidesIBA 12/2021
1	Nucleocapsid ProteinsIBA 01/2021
1	MacrolidesIBA 12/2020
1	beta-LactamsIBA 12/2020
1	Conjugate VaccinesIBA 10/2020
1	Immunoglobulin G (IgG)IBA 09/2020
1	N-acetyltalosaminuronic acid (NAT)IBA 09/2020
1	Immunoglobulin A (IgA)IBA 09/2020
1	Immunoglobulin M (IgM)IBA 09/2020
1	AcidsIBA 03/2020
1	Pertussis ToxinIBA 01/2020
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2020
1	Surface Antigens (Surface Antigen)IBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 10/2019
1	Methionine (L-Methionine)FDA Link 10/2019
1	AminopeptidasesIBA 10/2019
1	Interferon-gamma (Interferon, gamma)IBA 10/2019
1	IronIBA 12/2018
1	Fimbriae Proteins (Pilin)IBA 12/2018
1	Diphtheria Toxoid (Vaccine, Diphtheria)FDA Link 12/2018
1	ChlorhexidineIBA 11/2018
1	Sulfates (Sulfates, Inorganic)IBA 01/2018
1	incobotulinumtoxinA FDA Link 09/2015
1	NeurotoxinsIBA 09/2015
1	Azithromycin (Zithromax)FDA LinkGeneric 08/2015
1	FluoroquinolonesIBA 09/2014
1	Iron Chelating AgentsIBA 02/2014
1	Influenza Vaccines (Influenza Vaccine)FDA Link 04/2012
1	OligonucleotidesIBA 04/2010
1	Rifampin (Rifampicin)FDA LinkGeneric 04/2010
1	Antiviral Agents (Antivirals)IBA 09/2009
1	Complement System Proteins (Complement)IBA 07/2007

Therapy/Procedure

4	Therapeutics 01/2021 - 09/2009
1	Incubators 01/2022
1	Cardiopulmonary Bypass (Heart-Lung Bypass) 12/2018
1	Operative Surgical Procedures 12/2018
1	Retreatment 01/2017
1	Immunotherapy 01/2011
1	Intravesical Administration 01/2011
1	Critical Care (Surgical Intensive Care) 01/2004